ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,462 | -91.8% | 2,891 | -89.1% | 0.01% | -53.8% |
| Q1 2023 | $958,830 | -8.8% | 26,612 | 0.0% | 0.01% | -18.8% |
| Q4 2022 | $1,051,706 | -99.9% | 26,612 | 0.0% | 0.02% | 0.0% |
| Q3 2022 | $1,069,270,000 | +47.1% | 26,612 | +53.9% | 0.02% | +77.8% |
| Q2 2022 | $726,956,000 | -0.6% | 17,292 | -7.8% | 0.01% | +12.5% |
| Q1 2022 | $731,006,000 | -37.8% | 18,763 | -36.4% | 0.01% | -33.3% |
| Q4 2021 | $1,174,858,000 | +9.3% | 29,482 | -0.8% | 0.01% | +9.1% |
| Q3 2021 | $1,074,587,000 | +34.5% | 29,734 | +52.5% | 0.01% | +37.5% |
| Q2 2021 | $798,977,000 | -7.7% | 19,492 | +12.7% | 0.01% | -20.0% |
| Q4 2020 | $865,465,000 | – | 17,292 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |